Clinical trial
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
NCT00005603 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00005603 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia |
| Official title | ALinC 17: Protocol for Patients With Newly Diagnosed High Risk Acute Lymphoblastic Leukemia (ALL) - Evaluation of the Augmented BFM Regimen: A Phase III Study |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, mercaptopurine, methotrexate, prednisone, thioguanine and 1 more |
| Enrollment | 276 |
| Start date | Mar 1, 2000 |
| Primary completion | Sep 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 20, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: